Related references
Note: Only part of the references are listed.Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?
Ivan R. Vogelius et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
Alan J. Katz et al.
RADIATION ONCOLOGY (2013)
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King et al.
RADIOTHERAPY AND ONCOLOGY (2013)
LATER OUTCOMES AND ALPHA/BETA ESTIMATE FROM HYPOFRACTIONATED CONFORMAL THREE-DIMENSIONAL RADIOTHERAPY VERSUS STANDARD FRACTIONATION FOR LOCALIZED PROSTATE CANCER
Felix Leborgne et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
LONG-TERM OUTCOMES FROM A PROSPECTIVE TRIAL OF STEREOTACTIC BODY RADIOTHERAPY FOR LOW-RISK PROSTATE CANCER
Christopher R. King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CARCINOMA: FINAL RESULTS OF PHASE III RANDOMIZED TRIAL
Eric E. Yeoh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
Thomas P. Boike et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer
Michael J. Zelefsky et al.
UROLOGY (2011)
High-Dose-Rate Prostate Brachytherapy An Excellent Accelerated-Hypofractionated Treatment for Favorable Prostate Cancer
Alvaro A. Martinez et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
PHASE II TRIAL OF COMBINED HIGH-DOSE-RATE BRACHYTHERAPY AND EXTERNAL BEAM RADIOTHERAPY FOR ADENOCARCINOMA OF THE PROSTATE: PRELIMINARY RESULTS OF RTOG 0321
I-Chow Hsu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Stereotactic body radiotherapy for organ-confined prostate cancer
Alan J. Katz et al.
BMC UROLOGY (2010)
Virtual HDRSM cyberknife treatment for localized prostatic carcinoma:: Dosimetry comparison with hdr brachytherapy and preliminary clinical observations
Donald B. Fuller et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2007)
Use of individual fraction size data from 3756 patients to directly determine the α/β ratio of prostate cancer
Scott G. Williams et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
First-year PSA, kinetics and minima after prostate cancer radiotherapy are predictive of overall survival
Rex Cheung et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
STH Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prostate-specific antigen (PSA) bounce and other fluctuations: Which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy
T Pickles
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate - A randomized controlled trial
AL Zietman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
H Lukka et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results
DJ Demanes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
JR Sathya et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer
L Åström et al.
RADIOTHERAPY AND ONCOLOGY (2005)
3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer -: A pilot study
T Martin et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2004)
A zero psa slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancer
R Takamiya et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: Analysis of a prostate cancer randomized radiation dose escalation trial
A Pollack et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer
AA Martinez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Is α/β for prostate tumors really low?
J Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report
AA Martinez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial
Y Yoshioka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
